title: In-hospital costs of coronary stent implantation with and without eptifibatide (the ESPRIT Trial). Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin.
authors.affiliation: Cardiovascular Division, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA. djc@hsph.harvard.edu
authors.forename: David J
authors.initials: DJ
authors.lastname: Cohen
authors.forename: J Conor
authors.initials: JC
authors.lastname: O'Shea
authors.forename: Cindy M
authors.initials: CM
authors.lastname: Pacchiana
authors.forename: Glenn
authors.initials: G
authors.lastname: Levine
authors.forename: Ian
authors.initials: I
authors.lastname: Sarembock
authors.forename: James
authors.initials: J
authors.lastname: Slater
authors.forename: Eric
authors.initials: E
authors.lastname: Conn
authors.forename: Jack
authors.initials: J
authors.lastname: Smith
authors.forename: James E
authors.initials: JE
authors.lastname: Tcheng
mesh_terms: D015906:Angioplasty, Balloon, Coronary / Q000191:economics*; D003324:Coronary Artery Disease / Q000628:therapy*; D018592:Cross-Over Studies; D004311:Double-Blind Method; D000077542:Eptifibatide; D005260:Female; D017721:Hospital Costs; D006801:Humans; D007902:Length of Stay; D008297:Male; D008875:Middle Aged; D010455:Peptides / Q000191:economics / Q000627:therapeutic use*; D010975:Platelet Aggregation Inhibitors / Q000191:economics / Q000627:therapeutic use*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*; D016032:Randomized Controlled Trials as Topic; D015607:Stents; D014481:United States
chemical_list: D010455:Peptides; D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D000077542:Eptifibatide